Lisata Therapeutics to be acquired by Kuva Labs [Yahoo! Finance]
Lisata Therapeutics, Inc. (LSTA)
Company Research
Source: Yahoo! Finance
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) , a clinical-stage pharmaceutical company developing therapies to treat advanced solid tumors and other serious diseases, announced that it has agreed to be acquired by privately held Kuva Labs. Under the terms of a definitive agreement, Kuva will launch a tender offer to purchase all outstanding Lisata shares for $5 per share in cash at closing, plus one contingent value right (CVR) per share. Shares of Lisata, which closed at $4.18 on Friday, surged almost 20% premarket. The CVR could provide an additional cash payment of $1 per share if a New Drug Application or similar regulatory filing for a product containing certepetide is submitted or formally accepted for review by the US Food and Drug Administration or another regulatory authority before the earlier of seven years after closing or termination of the CVR agreement. If the milestone is not achieved within that period, no additional payment will be made under the CVR. The
Show less
Read more
Impact Snapshot
Event Time:
LSTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LSTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LSTA alerts
High impacting Lisata Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LSTA
News
- Shareholder Alert: The Ademi Firm investigates whether Lisata Therapeutics Inc. is obtaining a Fair Price for its Public ShareholdersPR Newswire
- Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc. [Yahoo! Finance]Yahoo! Finance
- Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.GlobeNewswire
- Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTAPR Newswire
LSTA
Earnings
- 11/6/25 - Beat
LSTA
Sec Filings
- 3/12/26 - Form 10-K
- 3/9/26 - Form SC14D9C
- 3/9/26 - Form 8-K
- LSTA's page on the SEC website